Recurrent breast cancer Sentinel node biopsie Recidief mammacarcinoom Schildwachtklierprocedure
Conditions
Interventions
Lymfatic Mapping and sentinel lymph node biopsie.
Sponsors
The principal investigator of this study is mrs. A. Maaskant-Braat, resident surgery
Eligibility
Inclusion criteria
Inclusion criteria: 1. Women above 18 years old with locally recurrent breast cancer after earlier BCT or modified radical mastectomy. 2. Operable cytological /histological confirmed locally recurrent breast cancer. 3. Having obtained an informed consent.
Exclusion criteria
Exclusion criteria: 1. Proven ipsi- or contralateral regional lymph node metastases (ultrasound and FNA). 2. Known to be allergic to “99mTc-colloidal albumin” or blue dye injection fluids.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Registration of technical feasibility of lymphatic mapping and sentinel node biopsy in patients with locally recurrent breast cancer. - Registration of success rate of lymphatic mapping and SNB in patients with locally recurrent breast cancer. - Registration of validity of lymphatic mapping and sentinel node biopsy in patients with locally recurrent breast cancer. | — |
Secondary
| Measure | Time frame |
|---|---|
| - Registration of lymphatic drainage pathways in patients with locally recurrent breast cancer. - Registration of sentinel lymph node status in patients with locally recurrent breast cancer. - Registration of possible influence of lymphatic mapping and SNB on therapeutic decisions in patients with locally recurrent breast cancer. | — |
Contacts
Public ContactA. Maaskant-Braat
Catharina ziekenhuis Eindhoven Afdeling chirurgie
Outcome results
None listed